Abrocitinib and Ciclosporin (Sandimmun Neoral 100 mg Yumuşak Jelatin Kapsül): interaction and safety
This source-based reference is not a personal treatment recommendation. The relevance and management of an interaction depend on the exact products, route, dose and clinical situation.
Interaction mechanism
Additional systemic immunosuppression can increase serious infection and other adverse-effect risks.
Clinical significance and safety
Abrocitinib labeling does not recommend combination with other immunosuppressants. Sandimmun Neoral 100 mg Yumuşak Jelatin Kapsül represents systemic immunosuppressive therapy, so this overlap requires specialist review and is not a routine self-selected combination. Do not interrupt an established transplant or inflammatory-disease regimen without its treating team.
Using this information
This is a source-based reference record, not a recommendation to combine, stop or change medicines. A missing interaction record does not establish safe use. A qualified healthcare professional should consider the exact products, doses, other medicines and individual health circumstances.